Consumer Staples Select Sector

S&P 500

The Balanced Allocator

Comparable Companies - KO

The data includes 3 discretionary insider purchases totaling $998,676.36 and 24 discretionary insider sales totaling $2,495,212,225.54. Latest short interest is 0.9% of float with 1.8 days to cover. Top institutional holders are Berkshire Hathaway (9.3%), Vanguard Group (8.7%), and BlackRock (7.4%).

DIRECTOR

CHAIRMAN AND CEO

EXECUTIVE VICE PRESIDENT

EVP & CHIEF OPERATING OFFICER

10% OWNER

INSIDER

PRESIDENT AND CFO

Amendment to Schedule 13D reporting the repurchase of all 18,835,460 shares of Coca-Cola Consolidated, Inc. by Carolina Coca-Cola Bottling Investments, Inc. from The Coca-Cola Trading Company LLC and termination of the Stock Rights and Restrictions Agreement, resulting in zero beneficial ownership.

Reporting beneficial ownership of 78,972,727 ordinary shares (17.1%) of Coca-Cola Europacific Partners plc by The Coca-Cola Company and its subsidiaries.

Remains in primary leadership role; continues to lead the 'Total Beverage Company' strategy as of early 2026.

Chairman and Chief Executive Officer

Continues to oversee global finance and operations following his elevation to President in 2022.

President and Chief Financial Officer

Verified as current EVP; oversees global marketing and category leads.

Executive Vice President and Global Chief Marketing Officer

Remains in role overseeing international operating units and bottling investments.

Executive Vice President and President, International Development

Continues to lead the North America Operating Unit (NAOU).

Executive Vice President and President, North America

Verified as a current member of the board while maintaining her role as Executive Chair of Banco Santander.

Independent Director

Verified as a current member of the board; also serves as CEO of Markel Group.

James Quincey

John Murphy

Ana Botín

Thomas S. Gayner

James Quincey's provenance is defined by a transition from operational leadership in Europe to a transformative CEO role focused on portfolio diversification. His track record is anchored by large-scale M&A (Costa, BodyArmor) and a significant restructuring of the global bottling system. His leadership style prioritizes asset-light operations and margin expansion, which has successfully insulated the company from volume declines in traditional sparkling categories. He is widely regarded as a disciplined capital allocator who balances aggressive brand acquisition with consistent dividend growth.

Acquisition of Costa Limited (Costa Coffee)

Acquisition of remaining stake in BodyArmor

Ana Botín brings immense global financial expertise and a proven record of navigating highly regulated, complex international markets. Her tenure at Santander demonstrates a sophisticated understanding of capital structure, risk management, and digital evolution. On the Coca-Cola board, her 'provenance' as a crisis-tested financial leader provides critical oversight for the company's global treasury and international expansion strategies, particularly in emerging markets where Santander has a deep footprint.

Share Buyback Program and Dividend Increase

Herb Allen

Bela Bajaria

Christopher C. Davis

Carolyn Everson

Maria Elena Lagomasino

Amity Millhiser

Caroline J. Tsay

David B. Weinberg

Keurig Dr Pepper Inc. is a leading beverage company in North America with an integrated model of brand ownership, manufacturing, and distribution, focusing on iconic beverage brands and brewing systems.

PepsiCo is a global food and beverage company with a diversified portfolio, focusing on convenient foods and beverages through a strong distribution network.

Monster Beverage Corporation is a developer, marketer, and distributor of energy drinks and other beverages, with a focus on innovation and brand building.

The Procter & Gamble Company is a global consumer goods company with a portfolio of daily-use products, focusing on superiority in product, package, brand communication, retail execution, and value.

The Company owns or leases production, processing, packaging, storage, warehousing and retail facilities worldwide, including principal bottling plants and distribution centers in the United States ($4,825 million) and internationally ($4,788 million). Property, plant and equipment (net) totaled $9,613 million, with major assets in buildings, improvements, machinery and equipment.

Coca-Cola's management under CEO James Quincey since 2017 has stewarded a Mature Compounder by extracting cash from a flat revenue base via 28.7% operating margins, 15.3% ROIC, and $40.0 billion dividends, strengthening the balance sheet to 1.7x net debt/EBITDA while delivering 16.0% Net Yield; strong incentives tied to EPS/FCF growth, proven internal track record, and expert board oversight outweigh mixed buyback timing and 0.8x M&A effectiveness, positioning the team as reliable stewards focused on per-share compounding despite modest growth.

The company is subject to various environmental protection statutes and regulations, including those relating to water use, wastewater discharge, air emissions, and solid and hazardous waste. Climate change may result in additional legal or regulatory requirements designed to reduce greenhouse gas emissions. The company faces risks from evolving sustainability regulatory requirements and legal proceedings related to plastic packaging environmental impacts.

As of December 31, 2025 and 2024, the company had approximately 65,900 and 69,700 employees, respectively, of which approximately 8,900 were located in the United States. Approximately 400 employees in North America were covered by collective bargaining agreements.

The company maintains rigorous product safety and quality standards, complies with laws and regulations regarding product safety, quality, advertising, labeling, and marketing, and addresses consumer concerns about ingredients and processing.

The company relies on a network of independent bottling partners, distributors, and suppliers for production and distribution. It faces risks from supply chain disruptions, including those related to raw material availability, and focuses on water sustainability and responsible sourcing of agricultural commodities.

Revenue grew only 1.9% YoY to $47.9 B, operating margin surged to 28.7% largely from expense cuts, and insiders have sold $2.5 B of stock in the past 12 months.

The FY2025 transcript described a $2.2 billion capex plan, with roughly 25% earmarked for company‑owned bottlers (e.g., fairlife New York plant, refillable infrastructure in Africa and Asia). The Innovation Dossier confirms that capex is classified as capacity expansion, supporting dairy‑capacity growth and sustainability initiatives.

Impairments in FY2025 included a $1.274 b African bottling‑asset write‑down, a $960 m BodyArmor trademark impairment, $44 m Latin‑America trademark write‑down, and smaller regional write‑downs (Nigeria, Ghana, Asia‑Pacific). The auditor identified valuation of indefinite‑life intangibles as a Critical Audit Matter, highlighting uncertainty around the recoverable amount of the $12.5 b trademark portfolio.

Capital deployed in FY2025 was directed toward fairlife capacity expansion, bottler digitalization, and sustainability projects—areas highlighted in the Innovation Dossier and transcript as growth‑oriented. However, recurring impairment charges (BodyArmor, African assets) and the modest capex level temper the upside. Overall, the new investments have generated returns that exceed the cost of capital, indicating value creation despite the low absolute capex spend.

Revolving Credit Facility / Lines of Credit

P/FCF

Manuel Arroyo

Annual cash incentives determined based on a formula with predefined financial and non-financial measures.

Director

Chairman & CEO

Henrique Braun

Nancy Quan

Advisory vote to approve executive compensation

Ratify the appointment of Ernst & Young LLP as Independent Auditors

Shareowner proposal regarding an assessment of non-sugar sweeteners

Shareowner proposal regarding a report on food waste

Shareowner proposal regarding creation of an improper influence board committee

Shareowner proposal regarding DEI goals in executive pay

Shareowner proposal regarding a report on brand image impacts

Shareowner proposal regarding a report on civil liberties in advertising services

Chairman of the Board and Chief Executive Officer

Executive Vice President and President, Global

Jennifer Mann

Executive Vice President and President, North America Operating Unit

The Coca-Cola Company is a total-beverage company that manufactures, markets and sells a broad portfolio of non-alcoholic beverages, including sparkling soft drinks, water, sports, coffee, tea, juice, dairy-based and plant-based drinks, and emerging categories. The business dates to 1886 in the United States and operates in more than 200 countries and territories, selling products under owned or licensed trademarks such as Coca-Cola, Sprite, Fanta, Diet Coke and many others.

Geographic segment covering Europe, the Middle East and Africa; includes Costa retail stores and bottling partners in the region.

Geographic segment covering Latin American countries; primarily concentrate sales to bottlers and limited finished-product operations.

Geographic segment covering the United States and Canada; includes concentrate sales, fountain syrup sales and finished-product operations.

Geographic segment covering Asia-Pacific markets; concentrate and finished-product sales to regional bottlers.

Consolidated bottling and distribution operations that produce and sell finished beverages directly to retailers.

Corporate functions including global strategy, finance, governance and shared services.

Held WACC 9.5% and base case revenue growth/terminal multiple constant, solved for Year 5 margin to justify $80.36 price.

Balance Sheet - Supplemental

Balance Sheet

Cash Flow Statement - Supplemental

Cash Flow Statement

Income Statement - Supplemental

Income Statement

Ratios

Valuation

Historical Ratios & Multiples - KO

The beverage industry is facing a volume trough, with Coca-Cola reporting flat unit case volumes in FY2025. While the company is outperforming peers in value share (19 consecutive quarters of gains), it is doing so in a shrinking or stagnant volume environment, making it increasingly dependent on pricing and mix for growth.

Coca-Cola is relevant for analysis at this moment due to the stock trading near all-time highs ($80.41) despite a significant slowdown in organic growth and a massive wave of insider selling.

IRS Transfer Pricing Litigation Ruling An adverse ruling could result in a $16 billion liability, significantly impacting the balance sheet and potentially forcing a reduction in share repurchases or a slowdown in dividend growth.

Margin Normalization in Quarterly Earnings As the company laps the aggressive expense cuts of FY2025, a failure to sustain the 28.7% operating margin will likely trigger a multiple de-rating.

Structural Volume Decline from GLP-1 Medications The widespread adoption of weight-loss drugs could permanently reduce the consumption of high-calorie sparkling beverages, which remain the company's primary cash flow driver.

Moat Erosion and Pricing Resistance In an inflationary environment, the company's reliance on price/mix (4% lift in FY2025) may reach a breaking point, leading to volume elasticities that impair total revenue.

The stewardship verdict is mixed. While the board is highly independent and possesses deep financial expertise (e.g., Finance Chair Christopher Davis and Director Ana Botín), the massive volume of insider selling ($2.5B) suggests a lack of alignment with shareholders at the current valuation. The governance outcome tree suggests that the status quo will likely continue, but the $16B IRS liability remains a 'black...

Liquidation value analysis is not relevant for the company's archetype ('Mature_Compounder') and was not performed.

Coca-Cola price target raised to $83 from $77 at Barclays

Coca-Cola price target raised to $85 from $82 at Evercore ISI

RBC Capital on Coca-Cola (KO): 'Expecting Fundamental Momentum'

UBS Reiterates Buy Rating on Coca-Cola (KO) Ahead of Q4 Earnings

Coca-Cola price target raised to $83 from $82 at Deutsche Bank

Coca-Cola (KO) PT Raised to $81 at Piper Sandler Following a 'Refreshing Update'

Coca-Cola price target raised to $77 from $71 at Barclays

Coca-Cola (KO) PT Raised to $82 at Evercore ISIMember Login

Situation: Current price is $79.84 versus fair value $49.97 (-37.4% expected return), and valuation confidence is stable. Debate: Bull case depends on IRS Transfer Pricing Litigation Ruling An adverse ruling could result in a $16 billion liability, significantly impacting the balance sheet and potentially forcing a reduction in share repurchases or a slowdown in dividend growth. Bear case centers on Structural Volume Decline from GLP-1 Medications The widespread adoption of weight-loss drugs could permanently reduce the consumption of high-calorie sparkling beverages, which remain the company's primary cash flow driver. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.

Executive Summary

The primary value driver is a necessary mean reversion of the valuation multiple as the market realizes the recent 28.7% operating margin is a peak driven by temporary expense cuts. The specific event that will unlock this realization is the normalization of SG&A spending and the potential $16B cash outflow from the IRS transfer pricing dispute. Downside protection is limited to the company's 2.6% dividend yield and robust 93% free cash flow conversion, which are insufficient to offset a 37% valuation gap.<ul><li>Driver: Valuation Mean Reversion</li><li>Catalyst: Margin Normalization and IRS Litigation Outcome</li><li>Protection: Strong Free Cash Flow and Dividend Yield</li></ul>Our variant perception is based on time arbitrage. The market is pricing the stock for a 'fade to average' over a much longer horizon than our analysis suggests is realistic, given the structural headwinds of GLP-1 medications and emerging market volume softness. While the consensus views the 28.7% operating margin as a new structural floor, our analysis of the 7.5-point margin jump reveals it was primarily expense-driven, with gross margins improving only 50 basis points, suggesting that pricing power is reaching its upper limit.This is a valuation-driven exit recommendation predicated on the belief that the market is overpaying for the durability of recent margin gains in a low-growth environment.

Core Investment Rationale

The Coca-Cola Company operates as a global beverage leader, primarily utilizing an asset-light model where it manufactures and sells beverage concentrates and syrups to a network of independent bottling partners. This strategy allows the company to maintain high returns on invested capital, currently at 15.3%, while shifting the capital-intensive bottling and distribution costs to partners. Revenue is generated through four primary categories: sparkling soft drinks, water/sports/coffee/tea, juice/dairy/plant-based, and emerging/alcoholic beverages. The current 'Total Beverage Company' strategy focuses on diversifying away from core soda into high-growth categories like fairlife (dairy) and Costa (coffee), though sparkling still dominates the cash flow profile.The company's moat is anchored by its portfolio of 32 billion-dollar brands, including Coca-Cola, Sprite, Fanta, and newer additions like fairlife and Topo Chico. These intangible assets, primarily trademarks, are valued at $12.5 billion on the balance sheet. Beyond brands, the company's core asset is its global distribution ecosystem, which provides a 7.4-percentage-point gross margin premium (61.6%) over the peer median (54.2%). Digital assets are becoming increasingly critical, with the 'myCoke' B2B platform and 'Coke Buddy' in India scaling to provide AI-driven ordering and logistics advantages for small retailers.The industry is a rational oligopoly dominated by Coca-Cola, PepsiCo, and Keurig Dr Pepper. Coca-Cola leads the non-alcoholic segment with $47.9B in revenue, significantly outpacing Keurig Dr Pepper's $16.6B. Competition is primarily focused on innovation and functional beverage categories rather than destructive price wars, as evidenced by gross margins remaining within a narrow 200-basis-point band over the last five years. However, the company faces increasing pressure from low-cost local entrants in emerging markets and the structural threat of GLP-1 weight-loss drugs on caloric beverage volumes.Coca-Cola has a history of consistent execution, maintaining a 63-year track record of dividend growth and a 5-year average revenue CAGR of 7.9%. However, the current situation is defined by a significant deceleration, with FY2025 revenue growth slowing to 1.9%. Management has successfully engineered a 7.5-point operating margin expansion to 28.7% through refranchising and productivity initiatives, but this has occurred against a backdrop of flat unit case volumes. The defining context for the investment today is the looming $16 billion IRS transfer pricing dispute, which represents a massive latent liability. Furthermore, the recent CEO transition to Henrique Braun signals a shift toward accelerating young adult recruitment and digital scaling, yet this occurs as insiders, including former CEO James Quincey, have sold over $2.4 billion in stock, suggesting leadership may view the current price as a cyclical peak.

Business & Situation

<ul><li>Bull Case: The 'myCoke' digital B2B platform creates a high-margin data and logistics moat that is currently underappreciated by the market. Continued expansion into functional and alcoholic categories (e.g., Jack & Coke RTD) provides a long-term growth runway that offsets sparkling volume declines.</li><li>Bear Case: The 28.7% operating margin is unsustainable and will revert to the 24-25% historical average as SG&A spending normalizes. GLP-1 medications and global sugar taxes represent a structural, permanent impairment to the core sparkling volume growth engine.</li></ul>The consensus view is that Coca-Cola is a 'safe haven' asset that has successfully transitioned to a higher structural margin profile. Investors are willing to pay a premium multiple (26.2x P/E) for the company's 15.3% ROIC and reliable dividend, viewing the recent expense-driven margin gains as permanent efficiency improvements. Macro headwinds like currency volatility and emerging market softness are seen as transitory, with the market expecting a return to mid-single-digit organic growth.The beverage industry is facing a volume trough, with Coca-Cola reporting flat unit case volumes in FY2025. While the company is outperforming peers in value share (19 consecutive quarters of gains), it is doing so in a shrinking or stagnant volume environment, making it increasingly dependent on pricing and mix for growth.Our differentiated view is that the market is overly focused on short-term margin expansion while underappreciating the durability of the $16 billion IRS tax headwind and the inevitable 'fade to average' of the company's profitability. The 7.5-point operating margin jump was achieved while gross margins only moved 50 basis points, proving that the gains are not coming from superior pricing power but from unsustainable expense cuts. Furthermore, the heavy insider selling-$2.5 billion in 12 months-acts as a clear signal that those with the most information believe the stock is fully valued. The governance friction of a $16 billion potential liability prevents 'value drift' and instead creates a significant 'valuation cliff' that the current 26x multiple does not account for.The debate between margin sustainability and volume stagnation is resolved by the valuation. Even if margins remain elevated, a 1.9% revenue growth rate cannot support a 26x P/E multiple for a Mature Compounder. The risk-reward is heavily skewed to the downside.Our analytical edge comes from a deeper appreciation of the company's intangible assets and switching costs, leading us to believe the market is underestimating the risk of a structural multiple de-rating as the company's growth profile shifts from 'Compounder' to 'Mature Utility'.

Core Thesis

James Quincey has served as CEO since 2017, successfully modernizing the company and diversifying the portfolio through the $4.9 billion Costa Coffee and $5.6 billion BodyArmor acquisitions. His tenure has been marked by a shift toward asset-light operations and margin expansion. However, the recent transition to Henrique Braun as CEO occurs during a period of heavy insider selling, with Quincey himself selling $26 million in stock in February 2026. This transition appears to be a planned succession, but the lack of insider buying at current levels raises questions about the new leadership's ability to drive incremental value from this price point.Management has demonstrated disciplined capital allocation, returning $40 billion in dividends and $3.9 billion in buybacks over the last five years. However, M&A effectiveness is subpar at 0.8x, evidenced by recurring impairments including a $960 million write-down of the BodyArmor trademark and a $1.27 billion impairment of African bottling assets.Management maintains high credibility in meeting EPS guidance (100% quarterly hit rate), but their narrative on pricing power is contradicted by the modest 0.5-point gross margin improvement versus the 7.5-point operating margin surge.<ul><li>Board Independence: 91% (10 of 11 directors)</li><li>Chairman/CEO Roles: Combined (James Quincey)</li><li>Chairman Tenure: 9 Years</li><li>Insider Ownership: 0.62%</li><li>Shareholder Rights: Majority Voting, Proxy Access, No Poison Pill Disclosed</li></ul>The stewardship verdict is mixed. While the board is highly independent and possesses deep financial expertise (e.g., Finance Chair Christopher Davis and Director Ana Botín), the massive volume of insider selling ($2.5B) suggests a lack of alignment with shareholders at the current valuation. The governance outcome tree suggests that the status quo will likely continue, but the $16B IRS liability remains a 'black swan' that could force a reset of the capital allocation strategy.

Leadership & Governance

The valuation floor is anchored to the Bear Case DCF value of $30.22, which models a permanent erosion of the company's moat, a 1.5% decline in revenue growth, and margin compression to 21.5%.The base case assumes 2.3% revenue growth and operating margins normalizing to 24.1%, resulting in a fair value of $40.76 per share.The bull case assumes the digital 'myCoke' platform drives revenue growth to 5.5% and margins to 26.5%. Blue-Sky Potential: $47.60.The bear case is defined by a scenario of moat erosion and declining profitability due to GLP-1 impacts and regulatory headwinds. The final Bear Case value is $30.22, determined directly by the Bear Case DCF scenario.

Valuation Context

<ul><li>IRS Transfer Pricing Litigation Ruling An adverse ruling could result in a $16 billion liability, significantly impacting the balance sheet and potentially forcing a reduction in share repurchases or a slowdown in dividend growth.</li><li>Margin Normalization in Quarterly Earnings As the company laps the aggressive expense cuts of FY2025, a failure to sustain the 28.7% operating margin will likely trigger a multiple de-rating.</li><li>Coca-Cola is relevant for analysis at this moment due to the stock trading near all-time highs ($80.41) despite a significant slowdown in organic growth and a massive wave of insider selling.</li></ul>Coca-Cola is relevant for analysis at this moment due to the stock trading near all-time highs ($80.41) despite a significant slowdown in organic growth and a massive wave of insider selling.

Catalyst Path & Context

<ul><li>Structural Volume Decline from GLP-1 Medications The widespread adoption of weight-loss drugs could permanently reduce the consumption of high-calorie sparkling beverages, which remain the company's primary cash flow driver. Morgan Stanley research suggests a structural shift in consumer appetite could lower caloric beverage volumes by 2-3% annually.</li><li>Moat Erosion and Pricing Resistance In an inflationary environment, the company's reliance on price/mix (4% lift in FY2025) may reach a breaking point, leading to volume elasticities that impair total revenue. Unit case volumes were flat in FY2025, indicating that pricing gains are already being offset by volume stagnation.</li><li>The stewardship verdict is mixed. While the board is highly independent and possesses deep financial expertise (e.g., Finance Chair Christopher Davis and Director Ana Botín), the massive volume of insider selling ($2.5B) suggests a lack of alignment with shareholders at the current valuation. The governance outcome tree suggests that the status quo will likely continue, but the $16B IRS liability remains a 'black... Risk monitor: Current price $79.84 vs fair value $49.97, expected return -37.4%.</li></ul>

Primary Risks

<ul><li>Entry Target: No new entries: recommendation is Sell.</li><li>Stop Loss: No stop-loss needed because recommendation is Sell (no position).</li><li>Position Size: Position size is None under current recommendation and risk constraints.</li><li>Time Horizon: N/A for a Sell recommendation.</li></ul><ul><li>The company has already deposited $6 billion with the IRS and disclosed a gross unrecognized tax benefit of $857 million.</li><li>Management's 2026 guidance implies a normalization of margins as reinvestment in marketing and supply chain re-accelerates.</li><li>Morgan Stanley research suggests a structural shift in consumer appetite could lower caloric beverage volumes by 2-3% annually.</li></ul>A material re-acceleration of organic volume growth to >3% alongside a favorable settlement of the IRS tax dispute. Also require valuation reliability to improve before re-entering.

Actionable Parameters & Monitoring

KO appears overvalued (fair value $49.97 vs current $79.84, expected return -37.4%). Recommendation: Sell; do not allocate until valuation and risk profile reset.

Final Conclusion

Driver

Margin Normalization and IRS Litigation Outcome

Catalyst

Protection

The 'myCoke' digital B2B platform creates a high-margin data and logistics moat that is currently underappreciated by the market. Continued expansion into functional and alcoholic categories (e.g., Jack & Coke RTD) provides a long-term growth runway that offsets sparkling volume declines.

Bull Case

The 28.7% operating margin is unsustainable and will revert to the 24-25% historical average as SG&A spending normalizes. GLP-1 medications and global sugar taxes represent a structural, permanent impairment to the core sparkling volume growth engine.

Bear Case

Situation: Current price is $79.84 versus fair value $49.97 (-37.4% expected return), and valuation confidence is stable. Debate: Bull case depends on IRS Transfer Pricing Litigation Ruling An adverse ruling could result in a $16 billion liability, significantly impacting the balance sheet and potentially forcing a reduction in share repurchases or a slowdown in dividend growth. Bear case centers on Structural Volume Decline from GLP-1 Medications The widespread adoption of weight-loss drugs could permanently reduce the consumption of high-calorie sparkling beverages, which remain the company's primary cash flow driver. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.

The strategy evolved from a broad 'all-weather' focus on portfolio power, marketing transformation, and system alignment to a more targeted acceleration phase under new leadership, emphasizing young adult recruitment, consumer closeness for speed-to-market, and scaling the RAD digital system.

Method	Implied Value	Weight	Weighted Value
DCF	$40.70	50%	$20.35
Comps	$55.69	30%	$16.71
Historicals	$64.57	20%	$12.91
Total Weighted			$49.97

KO

Company Overview

Price History